chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; diarrhea; headache; chills; sweating; slept all day; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: En6208), administered in left arm, on 10Mar2021 at 11:00 AM (at the age of 61-years-old) at 1st dose, single dose for COVID-19 immunisation. The patient was not pregnant. Medical history included known allergies to penicillin. The patient had not COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications were not reported. No other vaccine received in four weeks. The patient previously took aspirin and experienced allergies. The patient experienced vomiting, diarrhea, headache, chills, sweating, slept all day on 11Mar2021 at 01:00 AM. No treatment was administered for the adverse events. The patient had recovered with lasting effects from the events in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph node under left arm associated with soreness; This is a spontaneous report from a contactable consumer  reporting for herself.     A 51-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 11Mar2021 14:15 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  The patient medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; fluconazole (FLUCONAZOLE) taken for an unspecified indication, start and stop date were not reported; ascorbic acid, cyanocobalamin, nicotinamide, pantothenic acid, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (T-VITES) taken for an unspecified indication, start and stop date were not reported.  The patient experienced lymphadenopathy on 13Mar2021 10:30 with outcome of not recovered.    Course of the event On second morning after second dose, I woke up with swollen lymph node under left arm, vaccination was also given in my left arm. It looks fatty/ swollen and has soreness/ pain associated with it.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Myalgia
Clinical narrative: Injection site pain; redness; tiredness; headache; muscle pain; chills; This is a spontaneous report received from a contactable consumer (patient). A 71-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via unspecified route of administration in left arm on 11Mar2021 12:15 PM (at the age of 71-year-old) as 1st dose, single dose for COVID-19 immunisation. Vaccine facility type was reported as doctor's office/urgent care. The patient's medical history included heart attack, thyroid, lupus and COVID prior vaccination. Patient's known allergies were reported as none that she knew off unless you want to include this vaccine (as reported). The patient was taking unspecified concomitant medications administered in two weeks (reported as there was not enough room to list). No other vaccine administered in four weeks. On 11Mar2021 07:00 PM the patient experienced Injection site pain, redness, tiredness, headache, muscle pain and chills. No treatment was received due to the events. The patient was not tested for COVID post vaccination. The outcome of the events was resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; redness; tiredness; headache; muscle pain; chills; This is a spontaneous report received from a contactable consumer (patient). A 71-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via unspecified route of administration in left arm on 11Mar2021 12:15 PM (at the age of 71-year-old) as 1st dose, single dose for COVID-19 immunisation. Vaccine facility type was reported as doctor's office/urgent care. The patient's medical history included heart attack, thyroid, lupus and COVID prior vaccination. Patient's known allergies were reported as none that she knew off unless you want to include this vaccine (as reported). The patient was taking unspecified concomitant medications administered in two weeks (reported as there was not enough room to list). No other vaccine administered in four weeks. On 11Mar2021 07:00 PM the patient experienced Injection site pain, redness, tiredness, headache, muscle pain and chills. No treatment was received due to the events. The patient was not tested for COVID post vaccination. The outcome of the events was resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: Tiredness; headache; muscle pain; nausea; overall unwell feeling; lymph nodes under my right arm where injection was given, swelled to the size of a baseball, and was tender and uncomfortable; lymph nodes under my right arm where injection was given, swelled to the size of a baseball, and was tender and uncomfortable; This is a spontaneous report from a contactable consumer (patient).  A 52-year-old female patient (not pregnant) received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number ENG202), via an unspecified route of administration, in Right Arm on 10Mar2021 at 09:45 AM(at 52 years) as single dose for covid-19 immunisation. Medical history included possibly allergy to sulphuric a long time ago. Concomitant medications were not reported.  On 10Mar2021 at 08:45 PM, the patient experienced tiredness, headache, muscle pain, nausea, overall unwell feeling; her lymph nodes under right arm (where injection was given) swelled to the size of a baseball and was tender and uncomfortable. No treatment given. The final outcome of the events was not recovered.No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Tiredness; headache; muscle pain; nausea; overall unwell feeling; lymph nodes under my right arm where injection was given, swelled to the size of a baseball, and was tender and uncomfortable; lymph nodes under my right arm where injection was given, swelled to the size of a baseball, and was tender and uncomfortable; This is a spontaneous report from a contactable consumer (patient).  A 52-year-old female patient (not pregnant) received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number ENG202), via an unspecified route of administration, in Right Arm on 10Mar2021 at 09:45 AM(at 52 years) as single dose for covid-19 immunisation. Medical history included possibly allergy to sulphuric a long time ago. Concomitant medications were not reported.  On 10Mar2021 at 08:45 PM, the patient experienced tiredness, headache, muscle pain, nausea, overall unwell feeling; her lymph nodes under right arm (where injection was given) swelled to the size of a baseball and was tender and uncomfortable. No treatment given. The final outcome of the events was not recovered.No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Myalgia, Pain
Clinical narrative: Migraine headache; extreme fatigue/ tiredness; muscle ache; pain; This is a spontaneous report from a contactable Physician (patient). A 46-year-old female patient not pregnant received first dose of bnt162b2 (BNT162B2), intramuscular, administered in Arm Left on 23Feb2021 09:45 (Lot number was not reported) as single dose for covid-19 immunisation (at age of 46-year-old). Medical history included hypothyroidism, Migraine headaches, allergy to sulfa. Concomitant medications in two weeks included levothyroxine sodium (LEVOXYL); erenumab aooe (AIMOVIG). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 03:00 patient experienced migraine headache, extreme fatigue and tiredness, muscle ache and pain. No treatment was received. Patient did not have COVID prior vaccination and also patient was not tested for COVID post vaccination. Patient recovered from the events. No Follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Nausea, Vaccination site pain
Clinical narrative: I feel tiredness; headache; injection site pain; nauseas; feeling unwell; This is a spontaneous report from contactable Healthcare Professional. A non-pregnant 39-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered in Hospital via an unspecified route in left arm on 12Mar2021 08:00, at 39 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient didn't receive any other vaccine in the previous 4 weeks. The patient was not diagnosed with COVID-19 prior vaccination and didn't test positive for COVID-19 post vaccination. On 12Mar2021 08:00 the patient felt tiredness and experienced headache, injection site pain, nauseas and feeling unwell. No treatment was administered for the events. At the time of the report the outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dysgeusia, Fatigue, Pain in extremity, Paranasal sinus hypersecretion
Clinical narrative: within 6 hrs huge sinus discharge, medicine taste mucus down bck of throat; within 6 hrs huge sinus discharge, medicine taste mucus down bck of throat; fatigue; Not clear minded; Sleep somewhat interrupted; aching legs; This is a spontaneous report from a contactable consumer reporting for herself.   A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: FN6199) on 04Mar2021 at 11:15 at single dose via an unspecified route of administration on arm left for COVID-19 immunization. Relevant medical history included chronic diastolic heart failure and hypothyroidism. Concomitant medications included apixaban (ELIQUIS), lisinopril, metoprolol, and levothyroxine. On 04Mar2021 at 18:00 patient started experiencing sinus discharge, medicine taste mucus down back of throat, no fever lasted 4 days lessening each day, then major fatigue set in and has lasted approximately a week.  The patient also presented with not clear minded, sleep somewhat interrupted and aching legs. No treatment was received. At the time of the reporting the patient was recovering from the events.   No follow up attempts are possible,  No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: within 6 hrs huge sinus discharge, medicine taste mucus down bck of throat; within 6 hrs huge sinus discharge, medicine taste mucus down bck of throat; fatigue; Not clear minded; Sleep somewhat interrupted; aching legs; This is a spontaneous report from a contactable consumer reporting for herself.   A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: FN6199) on 04Mar2021 at 11:15 at single dose via an unspecified route of administration on arm left for COVID-19 immunization. Relevant medical history included chronic diastolic heart failure and hypothyroidism. Concomitant medications included apixaban (ELIQUIS), lisinopril, metoprolol, and levothyroxine. On 04Mar2021 at 18:00 patient started experiencing sinus discharge, medicine taste mucus down back of throat, no fever lasted 4 days lessening each day, then major fatigue set in and has lasted approximately a week.  The patient also presented with not clear minded, sleep somewhat interrupted and aching legs. No treatment was received. At the time of the reporting the patient was recovering from the events.   No follow up attempts are possible,  No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: Anxiety; SOB; Numbness and Tingling to Arms; Pain at Injection Site; Numbness and Tingling to Arms; This is a spontaneous report from a contactable Other HCP.  A 32-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Left on 13Mar2021 13:00 (Batch/Lot Number: EN6207) age at vaccination of 32-years-old, as single dose, for covid-19 immunisation. Medical history included immune system disorder from an unknown date and unknown if ongoing. The patient was not pregnant and was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 13Mar2021 (13:00), the patient experienced anxiety, shortness of breath, numbness and tingling to arms. pain at injection site. The events resulted in Emergency room/department or urgent care. It was unknown if treatments were given. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome for the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blood test, Chills, Fatigue, Oropharyngeal pain
Clinical narrative: Extreme fatigue; sore throat; stomach pain; sore arm; chills; This is a spontaneous report from a contactable consumer or other non hcp reporting for herself.  A 59-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 15:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  Medical history included rheumatoid arthritis  , covid-19 from an unknown date prior vaccination.     The patient's concomitant medications were not reported.  The patient previously took amoxicillin and experienced hypersensitivity.  The patient experienced extreme fatigue  on 11Mar2021 14:30 with outcome of recovering , sore throat  on 11Mar2021 14:30 with outcome of recovering , stomach pain  on 11Mar2021 14:30 with outcome of recovering , sore arm  on 11Mar2021 14:30 with outcome of recovering , chills on 11Mar2021 14:30 with outcome of recovering.  The patient underwent lab tests and procedures which included blood test: negative   on 26Aug2020   , sars-cov-2 test: negative   on 10Mar2021  .    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: Extreme fatigue; sore throat; stomach pain; sore arm; chills; This is a spontaneous report from a contactable consumer or other non hcp reporting for herself.  A 59-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 15:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  Medical history included rheumatoid arthritis  , covid-19 from an unknown date prior vaccination.     The patient's concomitant medications were not reported.  The patient previously took amoxicillin and experienced hypersensitivity.  The patient experienced extreme fatigue  on 11Mar2021 14:30 with outcome of recovering , sore throat  on 11Mar2021 14:30 with outcome of recovering , stomach pain  on 11Mar2021 14:30 with outcome of recovering , sore arm  on 11Mar2021 14:30 with outcome of recovering , chills on 11Mar2021 14:30 with outcome of recovering.  The patient underwent lab tests and procedures which included blood test: negative   on 26Aug2020   , sars-cov-2 test: negative   on 10Mar2021  .    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vomiting
Clinical narrative: Nausea; severe vomiting; Fatigue; headache; This is a spontaneous report from a contactable Other HCP (patient)  A 45-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE2), intramuscular, administered in arm right on 05Mar2021 15:15 (Batch/Lot Number: EN6207) (at the age of 45) as single dose for covid-19 immunisation. Medical history was none. The patient's concomitant medications were none. No other vaccine was received in four weeks. Patient was not pregnant. The patient experienced nausea on 05Mar2021 21:00, severe vomiting on 05Mar2021 21:00, fatigue on 05Mar2021 21:00, headache on 05Mar2021 21:00. No Covid prior or post vaccination. The events were not treated. The events outcome was recovering.    No follow-up attempts are possible. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Computerised tomogram, Headache, Herpes zoster, Neuralgia
Clinical narrative: mild headache/severe headache; severe tingling and burning on left side of head; severe tingling and burning on left side of head; shingles; nerve reaction; This is a spontaneous report from a contactable consumer (patient herself). A 62-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number not reported) via an unspecified route of administration on 06Mar2021 at single dose for COVID-19 immunisation. The patient recently had the shingles vaccine. Relevant medical history and concomitant medications were not reported. The patient experienced a mild headache, 3 days after second dose the headache became more intense and she experienced severe tingling and burning on left side of head. Caller reports she went to her family doctor on Tuesday, was diagnosed with shingles and later sent to emergency room due to her severe headache and nerve reaction from shingles. Caller had a CT scan (negative). Caller reports that the headache is just now subsiding this week. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: mild headache/severe headache; severe tingling and burning on left side of head; severe tingling and burning on left side of head; shingles; nerve reaction; This is a spontaneous report from a contactable consumer (patient herself). A 62-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number not reported) via an unspecified route of administration on 06Mar2021 at single dose for COVID-19 immunisation. The patient recently had the shingles vaccine. Relevant medical history and concomitant medications were not reported. The patient experienced a mild headache, 3 days after second dose the headache became more intense and she experienced severe tingling and burning on left side of head. Caller reports she went to her family doctor on Tuesday, was diagnosed with shingles and later sent to emergency room due to her severe headache and nerve reaction from shingles. Caller had a CT scan (negative). Caller reports that the headache is just now subsiding this week. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: redness of injection site; arm aches; itching around injection site; Swelling around injection site; This is a spontaneous report from a contactable consumer reporting for herself. A non-pregnant 76-years-old female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered  via an unspecified route in right arm on 10Mar2021 13:30, at 76 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included hypertension, kidney disease, stroke survivor, breast cancer survivor and allergy to nichel and to shrimp, all from an unknown date. Historical vaccine included the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered via an unspecified route in right arm on 17Feb2021 13:30 , at 76 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Concomitant medications included allopurinol, metoprolol, atorvastatin, lisinopril and rivaroxaban (XAREL), all taken for an unspecified indication, since an unspecified date. The patient didn't receive any other vaccine in the previous 4 weeks. She was not diagnosed with COVID-19 prior to vaccination and was not tested positive for COVID-19 post vaccination. On 11Mar2021 08:00 the patient experienced redness of injection site, arm aches, itching around injection site and swelling around injection site. No treatment was received for the events. At the time of the report the events had not resolved yet.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pain, Paraesthesia, Peripheral swelling, Rash
Clinical narrative: burning sensation /I had burning in my hands; Hives; Stinging; they're a little swollen; tingling all over; I broke out in a rash at my neck; This is a spontaneous report from a contactable consumer who reported for herself, a 55-year-old female patient who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration, administered in left arm on 10Mar2021 at 12:30 (at the age of 55 years old) as first dose, single dose for COVID-19 immunization. Medical history included allergic to penicillin. Concomitant medication included ibuprofen (ADVIL). On 10Mar2021 at 16:30, the patient experienced hives, stinging, burning sensation within 4 hours of the injection. She further stated that 4 hours after administration of vaccine, she broke out in a rash at her neck and was tingling all over. She had burning in her hands and they're a little swollen. Urgent care put her on BENADRYL and prednisone twice and she doesn't know what to do because it's 'burny'. She was still feeling the tingling. The patient did not have COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events rash and swelling of hands was unknown, while the outcome of the remaining events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: burning sensation /I had burning in my hands; Hives; Stinging; they're a little swollen; tingling all over; I broke out in a rash at my neck; This is a spontaneous report from a contactable consumer who reported for herself, a 55-year-old female patient who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration, administered in left arm on 10Mar2021 at 12:30 (at the age of 55 years old) as first dose, single dose for COVID-19 immunization. Medical history included allergic to penicillin. Concomitant medication included ibuprofen (ADVIL). On 10Mar2021 at 16:30, the patient experienced hives, stinging, burning sensation within 4 hours of the injection. She further stated that 4 hours after administration of vaccine, she broke out in a rash at her neck and was tingling all over. She had burning in her hands and they're a little swollen. Urgent care put her on BENADRYL and prednisone twice and she doesn't know what to do because it's 'burny'. She was still feeling the tingling. The patient did not have COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events rash and swelling of hands was unknown, while the outcome of the remaining events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Cluster of cold sores on the exterior corner of the mouth; This is a spontaneous report from a contactable consumer (patient).   A 38-years-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6205, age at vaccination 38 years), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 as 1st dose, single for covid-19 immunisation at hospital. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks. No covid prior vaccination and covid tested post vaccination. On 11Mar2021, the patient experienced Cluster of cold sores on the exterior corner of the mouth appeared about 36 hours after the shot. It was reported that patient did not have history of cold sores or fever blisters. Did not run a fever. Treatment medications include Abreva topical. The outcome of event resolving   No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash around the injection site; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN6205), administered in left arm, on 07Mar2021 at 09:30 AM (at the age of 28-years-old) at 1st dose, single dose for COVID-19 immunisation. Medical history was not reported. The patient had not COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medication included triamcinolone injection (reported as other medications in two weeks). No other vaccine received in four weeks. The patient experienced rash around the injection site six days after the first dose of vaccine, on 13Mar2021 at 07:00 AM. No treatment was administered for the event. The patient was recovering from the event.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headache; Leg Aches; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 12Mar2021 10:30 (Lot number was not reported), at vaccination age of 68 years, as single dose for covid-19 immunisation. Previously the patient received first dose of bnt162b2 on 23-FEB-2021 01:30 PM in Right arm. There were no other vaccine in four weeks. Patient was not pregnant. No covid prior vaccination. No covid tested post vaccination. The patient medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID); magnesium; vitamin d nos; colestipol, all taken for an unspecified indication, start and stop date were not reported.  The patient experienced and leg aches (non-serious) on 13Mar2021 09:00 with outcome of recovered on unspecified date. No treatment was received.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: vertigo; dizziness; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: En6199), administered in the left arm, on 03Mar2021 at 12:00 PM (at the age of 39-years-old) at 1st dose, single dose for COVID-19 immunisation. The patient was not pregnant. Medical history was reported as none; patient had not known allergies. Patient had not COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications were not reported. No other vaccine received in four weeks and no other medications received in two weeks. The patient experienced, after 10 days of taking first dose, on 10Mar2021 at 19:00 (as reported), vertigo and dizziness. No treatment was administered for the events. The patient had not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: blood in urine; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-year-old non-pregnant female patient received bnt162b2 (Lot Number: 6206), dose 1 via an unspecified route of administration, administered in right arm on 12Mar2021 at 12:00 PM (at the age of 58 years old) as single dose for COVID-19 immunization. Medical history included asthma, thyroid, mild kidney disease, allergies, infertility, carpal tunnel, trigger finger, known allergies included Erythromycin. Concomitant medications in two weeks included Omeprazole, fluticasone propionate (FLONASE), famotidine, fluticasone propionate/ salmeterol xinafoate (ADVAIR), biotin. The patient had no other vaccine in four weeks. The patient experienced two events so far of blood in urine. First was the following day which was approx 23 hours after shot (13Mar2021 10:30 AM), then second noticed event of blood in urine was the next morning, approx 44 hours after shot. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. No treatment for the event. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rash that started on back of both arms, then hands and now feet and legs; kind of itchy; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6208, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 12Mar2021 09:45 (at the age of 51-years-old) as unknown, single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol and acute pancreatitis all from an unknown date. The patient previously took metronidazole (FLAGYL) and experienced allergies from an unknown date. Concomitant medications included losartan and sulfamethoxazole, trimethoprim both taken for an unspecified indication, start and stop date were not reported. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. On 13Mar2021 11:00, the patient experienced rash that started on back of both arms, then hands and now feet and legs and kind of itchy. It was unknown if treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was unknown.   No follow-up attempts are possible. No further information expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain, Vaccination site warmth
Clinical narrative: Injection sight warm to touch; pain at injection sight; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6203, expiration date not reported), via an unspecified route of administration, administered in the right arm on 11Mar2021 13:00 (at the age of 55-years-old), as first dose, single dose for COVID-19 immunisation. There was no pertinent medical history. Patient has no known allergies. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); venlafaxine hydrochloride (EFFEXOR); atorvastatin (LIPITOR [ATORVASTATIN]); lisinopril; omeprazole (PRILOSEC [OMEPRAZOLE]), all taken for an unspecified indication and start and stop dates were not reported. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced injection sight warm to touch (for 1 day) and pain at injection sight (for 2 days) on 11Mar2021 16:00. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 30Nov2020. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of vaccination site pain was recovered on 13Mar2021 and vaccination site warmth was 12Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, SARS-CoV-2 test, Vomiting
Clinical narrative: I have thrown up 3 times; had the chills; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6207; Expiration date was not reported), via unspecified route of administration in the left arm on 13Mar2021 04:30 PM (at the age of 19-years-old) as first dose, single dose for COVID-19 immunization at an urgent care center/ doctor's office. Medical history included COVID-19 from an unknown date (prior vaccination) and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient was not tested for COVID post vaccination. The patient has no known allergies. On 14Mar2021 08:30 AM (reported to be the morning after getting the vaccine), the patient experienced to have thrown up three times and had the chills. No treatment was taken for the events. The patient underwent lab test and procedure which included COVID-19 test: Positive on an unspecified date prior to vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal eruption, Pruritus, Rash
Clinical narrative: rash all over her body; itching; Rash/blotches in her mouth; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 06Mar2021, as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced rash all over her body, itching, and rash/blotches in her mouth on 09Mar2021. She said a dermatologist has looked at the rash. She also received a copy of the Fact Sheet for Recipients and Caregivers. Patient inquired on what to do to get the second dose. She doesn't know if she need to see somebody or if there is a need to get tested. She wants to get her second dose. Patient was looking to find out what she needs to get the vaccine, what kind of doctor, and what kind of prophylactic so she won't get itching again. Patient also inquired if there is someone that will do this kind of thing with Pfizer who will be able to give her permission to get this. The outcome of events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Red mark near injection site; mild soreness in arm near injection site; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6208; Expiration date were not reported), via unspecified route of administration in the left arm on 13Mar2021 06:15 PM (at the age of 35-years-old) as first dose, single dose for COVID-19 immunisation. The patient has no relevant medical history. The patient has no concomitant medications. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. On 14Mar2021 07:00 AM, the patient experienced red mark near injection site and mild soreness in arm near injection site. No treatment was taken for the events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin lesion
Clinical narrative: Lesions that itch on chin, lips belly button; Lesions that itch on chin, lips belly button; Rash on belly; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 09Mar2021 11:00 (at the age of 59-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included anklosing spondylitis, heart issues, arthritis, COVID-19 and allergies (unspecified) all from an unknown date. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient has unspecified medications in 2 weeks. On 11Mar2021 12:00 AM, the patient experienced lesions that itch on chin, lips belly button and rash on belly. Therapeutic measures were taken as a result of the events included medicated ointment. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bad headache; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 14Mar2021 09:45 (at the age of 61-years-old) , as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced bad headache on 14Mar2021. Patient would like to know if it is okay to take paracetamol (TYLENOL) to treat the headache. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Electric shock sensation
Clinical narrative: Brain zaps; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration on 06Mar2021 01:00 PM (at the age of 32-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included steroids allergy and penicillin allergy; both from an unknown date and unknown if ongoing. The patient has no concomitant medications. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient was not tested for COVID post vaccination. The patient has no known allergies. On 13Mar2021, the patient experienced brain zaps. No treatment was taken for the events. The outcome of the events was not recovered.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: getting a headache and got worse and worse; took everything she had not to throw up; arm was very sore; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 09Mar2021 15:00 (Batch/Lot number was not reported) at the age of 45 years old as 1st dose, single dose for COVID-19 vaccine. Medical history included had two kids naturally; known allergies with sulfa; hydrocephalus (found in 30's), no shunt. The patient rarely gets headaches. The patient was not pregnant. No other vaccines in four weeks. Concomitant medication included citalopram hydrobromide (CELEXA) taken for an unspecified indication, start and stop date were not reported; and unspecified multivitamin. The patient got her shot on 09Mar2021 15:00 (Tuesday afternoon). The patient's arm was very sore on 09Mar2021 (unknown time, Tuesday and Wednesday; also reported as on 11Mar2021 17:00), but she didn't take anything for the pain. Then on 10Mar2021 (Wednesday; also reported as (12Mar2021), she started getting a headache and got worse and worse throughout the day. It got so bad around 5PM that she thought she was going to have to go to the ER and it took everything she had not to throw up. She ate, drank and took a paracetamol (TYLENOL) and felt a little better. She does not get many headaches and has a very high tolerance for pain (had two kids naturally, no epidural or pain meds). This was the worst headache of her life and was considering not getting 2nd shot. 5 days later and she still has a minor headache. Also, she has never had a reaction to any vaccines in the past. The patient has no COVID prior vaccination and was not tested for COVID tested post vaccination. Outcome of event " took everything she had not to throw up" was unknown, while other events were recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Pain at shot location after vaccine; swelling in upper left arm at shot location after vaccine; This is a spontaneous report from a contactable consumer (patient).  A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 06Mar2021 08:45 (Batch/Lot number was not reported) at the age of 62 years old as 1st dose, single dose for COVID-19 immunization. Medical history included glaucoma from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. Patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included celecoxib (CELEXA); latanoprost; escitalopram oxalate (LEXAPRO); atorvastatin calcium, ezetimibe (STATIN EZ); taken for unspecified indications, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Mar2021 23:30, the patient experienced pain & swelling in upper left arm at shot location 7.5 days (as reported) after vaccine dose 1. No treatment was received for the adverse event. Outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Decreased appetite, Dysgeusia
Clinical narrative: Left arm has a burning sensation; Lack of appetite and everything taste like metal; Lack of appetite and everything taste like metal; This is a spontaneous report from a contactable consumer (patient). A 59-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 13Mar2021 10:30 (Batch/Lot number was not reported) (at the age of 59 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunisation. Medical history included allergies: Penicillin, sulfa, some miacines. The patient's concomitant medications were not reported Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. There were no other vaccine in four weeks. The patient experienced left arm has a burning sensation, lack of appetite and everything taste like metal, all on 13Mar2021 11:00, all with outcome of not recovered. Events resulted in Doctor or other healthcare professional office/clinic visit. There were no treatments received for the events.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash erythematous, Vomiting
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; batch/lot number was not reported), via an unspecified route of administration, administered in the left arm on 13Mar2021 15:00 (at the age of 63-years-old) as 1st dose, single dose for COVID-19 immunization. Medical history included hypertension and known allergies to strawberry and yogurt. Concomitant medications included biotin, sambucus nigra fruit (ELDERBERRY), losartan potassium, paracetamol (TYLENOL), and unspecified multivitamins. The patient was not pregnant at the time of vaccination. The patient had no COVID-19 prior to vaccination. The patient did not receive any other vaccinations within four weeks of the COVID-19 vaccination. On 13Mar2021 15:45, when the patient was leaving the facility, she experienced nausea and threw up. She had nausea for the rest of day and the day after. On 15Mar2021 15:00, the patient noticed a reddish rash on her forehead, breast, and chest. The patient did not receive any treatment for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event red rash was not recovered while the outcome of the events nausea and vomiting was unknown. The batch/lot number is not available despite the follow-up attempts made. Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Head discomfort, Peripheral coldness, Rhinorrhoea
Clinical narrative: Almost fell down; lightheadedness, dizziness; head pressure; cold hands and feet; runny nose; This is a spontaneous report from a contactable consumer (patient herself) via a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date, as 2nd dose, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that after the second dose "the 4th", the patient almost fell down, experienced head pressure, cold hands and feet. The patient also experienced adverse events such as lightheadedness, dizziness and runny nose after her 2nd dose. The patient took paracetamol (TYLENOL). The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.